firstwordpharmaMarch 27, 2017
Tag: Fosun , acquisition
India's Foreign Investment and Promotion Board (FIPB) has delayed a deal by Fosun to purchase Gland Pharmaceuticals for $1.4 billion, as reported Business Standard Friday.
In the planned deal reached in July 2016, Fosun would obtain a 86-percent stake in Gland.
The agreement was the first reached after India's government relaxed foreign direct investment norms in the country.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: